But there have been setbacks.
RELATED: FDA warns about companies marketing fraudulent products that claim to treat COVID-19
The FDA could be authorizing a coronavirus vaccine in a few weeks.
The Food and Drug Administration is holding an "emergency-use authorization" meeting about Pfizer's vaccine on Dec. 10.
The director of the FDA's Center for Biologics Evaluation and Research says a decision is expected within weeks, possibly days after that key meeting.
So far, Pfzier is the only company to apply for an emergency use authorization for a coronavirus vaccine.
VIDEO: 1st person in US to try COVID-19 vaccine talks side effects
The CDC plans to vote next week on where distribution of approved vaccines will begin.
A member of President elect Joe Biden's COVID Advisory Board warns against rushing a vaccine to market.
"The single biggest risk of rushing an approval would be Americans' distrust the vaccine. It's essential people feel confident this is a safe and effective vaccine," said Dr. Celene Gounder.
Meantime, AstraZeneca's coronavirus vaccine appears to be headed for an additional global trial as the drug maker tries to clear up confusion and mistakes surrounding encouraging results.
RELATED: AstraZeneca manufacturing error clouds vaccine study results
Questions are mounting over one of the fastest moving shots after the company acknowledged that a lower dosage level that appeared more effective - resulted from a manufacturing discrepancy.
"We still need to find out what's happening within the data, but one theory is that the smaller dose is similar to the actual infection," said ABC7 News Contributor Dr. Alok Patel.
As the virus reaches record highs in the U.S., it seems Americans ignored advice form health officials to stay home and avoid travel this Thanksgiving. More than six million people were flying for the holiday.
"What we don't want to see is yet another surge superimposed upon the surge you just described, which we'll realize three weeks from now, if we don't do these public health things," said Dr. Anthony Fauci from The National Institute of Allergy and infectious Diseases.
In a new report published in the Oxford Academic, a CDC researcher says Coronavirus cases may actually be eight times higher than reported here in the U.S. estimating 53 million total infections from late February Through September.
If you have a question or comment about the coronavirus pandemic, submit yours via the form below or here. Get the latest news, information and videos about the novel coronavirus pandemic here RELATED STORIES & VIDEOS:
- Map: CA counties that can, can't reopen under new rules
- COVID-19 risk calculator: The safest and most dangerous things to do this holiday season
- Updated number of COVID-19 deaths, cases in Bay Area
- COVID-19 Help: Comprehensive list of resources, information
- California EDD: The most commonly asked questions we get about unemployment and PUA
- Health experts urge flu shots in effort to avoid 'twindemic'
- How to tell the difference between seasonal allergies and coronavirus symptoms
- Here's which mask is better to protect from COVID-19
- First COVID-19 vaccine volunteers in US describe experience as Bay Area launches vaccine trials
- From salons to dinner parties: Experts rate the risk of 12 activities
- Coronavirus origin: Where did COVID-19 come from?
- What is a COVID-19 genetic, antigen and antibody test?
- What will it take to get a COVID-19 vaccine and how will it be made?
- What does COVID-19 do to your body and why does it spread so easily?
- Here's how shelter in place, stay at home orders can slow spread of COVID-19
- Coronavirus Timeline: Tracking major moments of COVID-19 pandemic in San Francisco Bay Area
- COVID-19 Diaries: Personal stories of Bay Area residents during novel coronavirus pandemic
- Coronavirus Doctor's Note: Dr. Alok Patel gives his insight into COVID-19 pandemic